Hexima to partner with DuPont for new fungal resistance technology

Extra funding announced for Australia's centre for plant genomics.

Sugar CRC CEO Dr Peter Twine sees the industry - with a little help from its friends in the research community - leading Australia into what he calls the 'carbohydrate economy'.

Biopharma company Novogen (ASX: NRT) has settled a patent infringement suit with giant US health food supplements retailer GNC. The lawsuit, which was settled out of court for an undisclosed sum, alleged that certain menopause products sold under the GNC brand infringed Novogen's red clover isoflavone patents.

The biocatalysis group at CSIRO Molecular Science, led by Prof Michael Zachariou, has established an impressive pipeline of research and is working towards developing a more sustainable and renewable chemical industry in Australia, writes Susan Williamson.

Biotechnology companies have agreed to make their data public in a bid to advance a project to decoding the genetic structure of corn several years ahead of schedule.

Maverick molecular geneticist Richard Jefferson is in New York this week to accept a prestigious Scientific American award as one of the magazine's 50 Global Technology Leaders of 2003.

Queensland-based diagnostics company PanBio (ASX:PBO) has ended the financial year with an anticipated loss, but expects the 2003-2004 year to be profitable, said chairman Ian Sandford today.

A $54 million Cooperative Research Centre using biotech to inject fresh life into the economics of the sugar industry is due to open for business next month.

Novogen’s US-based licensee The Solae Company has filed patent infringement suits against two of America’s biggest dietary and health supplement makers.

US giant Dow Corning's investment in Australian nanotechnology has deepend with a series of high-profile Dow-related appointments to the board and management of Starpharma's US subsidiary Dendritic Nanotechnologies.